Literature DB >> 34205249

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity.

Simona S Ghanem1, Hend S Fayed1,2, Qi Zhu3, Jia-Hong Lu3, Nishant N Vaikath1, Janarthanan Ponraj4, Said Mansour4, Omar M A El-Agnaf1,2.   

Abstract

The accumulation and aggregation of α-synuclein (α-syn) is the main pathologic event in Parkinson's disease (PD), dementia with Lewy bodies, and multiple system atrophy. α-Syn-seeded fibril formation and its induced toxicity occupy a major role in PD pathogenesis. Thus, assessing compounds that inhibit this seeding process is considered a key towards the therapeutics of synucleinopathies. Using biophysical and biochemical techniques and seeding-dependent cell viability assays, we screened a total of nine natural compounds of alkaloid origin extracted from Chinese medicinal herbs. Of these compounds, synephrine, trigonelline, cytisine, harmine, koumine, peimisine, and hupehenine exhibited in vitro inhibition of α-syn-seeded fibril formation. Furthermore, using cell viability assays, six of these compounds inhibited α-syn-seeding-dependent toxicity. These six potent inhibitors of amyloid fibril formation and toxicity caused by the seeding process represent a promising therapeutic strategy for the treatment of PD and other synucleinopathies.

Entities:  

Keywords:  Parkinson’s disease; seeded fibril formation; α-synuclein

Year:  2021        PMID: 34205249     DOI: 10.3390/molecules26123736

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  2 in total

1.  A Screen of Autophagy Compounds Implicates the Proteasome in Mammalian Aminoglycoside-Induced Hair Cell Damage.

Authors:  Clara Draf; Taylor Wyrick; Eduardo Chavez; Kwang Pak; Arwa Kurabi; Anke Leichtle; Stefan Dazert; Allen F Ryan
Journal:  Front Cell Dev Biol       Date:  2021-10-26

2.  Caffeine Consumption and Dementia: Are Lewy Bodies the Link?

Authors:  Marilyn C Cornelis; David A Bennett; Sandra Weintraub; Julie A Schneider; Martha Clare Morris
Journal:  Ann Neurol       Date:  2022-03-31       Impact factor: 11.274

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.